Related Experiment Video
Updated: Oct 1, 2025

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy
Published on: April 3, 2018
Transcriptional regulators of human oncoviruses: structural and functional implications for anticancer therapy
Ivona Nečasová1,2, Martin Stojaspal1,2, Edita Motyčáková1,2
1Institute of Biophysics of the Czech Academy of Sciences, Scientific Incubator, Královopolská 135, Brno 612 65, Czech Republic.
Abstract:
Transcription is often the first biosynthetic event of viral infection. Viruses produce preferentially viral transcriptional regulators (vTRs) essential for expressing viral genes and regulating essential host cell proteins to enable viral genome replication. As vTRs are unique viral proteins that promote the transcription of viral nucleic acid, vTRs interact with host proteins to suppress detection and immune reactions to viral infection. Thus, vTRs are promising therapeutic targets that are sequentially and structurally distinct from host cell proteins. Here, we review vTRs of three human oncoviruses: HBx of hepatitis B virus, HBZ of human T-lymphotropic virus type 1, and Rta of Epstein-Barr virus. We present three cunningly exciting and dangerous transcription strategies that make viral infections so efficient. We use available structural and functional knowledge to critically examine the potential of vTRs as new antiviral-anticancer therapy targets. For each oncovirus, we describe (i) the strategy of viral genome transcription; (ii) vTRs' structure and binding partners essential for transcription regulation; and (iii) advantages and challenges of vTR targeting in antiviral therapies. We discuss the implications of vTR regulation for oncogenesis and perspectives on developing novel antiviral and anticancer strategies.
Insights
Viral transcriptional regulators (vTRs) are key to viral infections and oncogenesis. Targeting these unique viral proteins offers a promising strategy for developing novel antiviral and anticancer therapies.
Area of Science:
- Virology
- Molecular Biology
- Oncology
Background:
- Viral transcriptional regulators (vTRs) are essential viral proteins that drive viral gene expression and replication.
- vTRs interact with host proteins to evade immune detection, making them critical in viral pathogenesis and oncogenesis.
- vTRs are distinct from host proteins, presenting them as attractive therapeutic targets.
Purpose of the Study:
- To review the transcription strategies of vTRs from three human oncoviruses: hepatitis B virus (HBx), human T-lymphotropic virus type 1 (HBZ), and Epstein-Barr virus (Rta).
- To critically examine the potential of vTRs as therapeutic targets for antiviral and anticancer strategies.
- To discuss the implications of vTR regulation in oncogenesis and future therapeutic perspectives.
Main Methods:
- Literature review of available structural and functional data on vTRs from HBx, HBZ, and Rta.
- Analysis of viral genome transcription strategies employed by these vTRs.
- Examination of vTRs' structure, binding partners, and their roles in transcription regulation.
Main Results:
- Detailed description of the distinct transcription strategies of HBx, HBZ, and Rta.
- Identification of key host binding partners crucial for vTR-mediated transcription regulation.
- Evaluation of the advantages and challenges associated with targeting these vTRs in therapeutic contexts.
Conclusions:
- vTRs employ sophisticated strategies to manipulate host transcription machinery, facilitating viral replication and oncogenesis.
- Targeting vTRs presents a viable approach for developing novel antiviral and anticancer therapies due to their unique viral nature.
- Further research into vTR structure-function relationships can unlock new avenues for therapeutic intervention against viral-associated cancers.
Related Concept Videos
Mechanisms of Retrovirus-induced Cancers
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Leaky Scanning

